Determination of epalrestat in human plasma by high performance liquid chromatography and its pharmacokinetics

余自成,卢恕,邵云弟,刘长义,周玉琢

DOI: https://doi.org/10.3321/j.issn:1001-2494.2000.03.016

2000-01-01

Abstract:OBJECTIVE: To develop a reversed-phase liquid chromatographic method for the determination of epalrestat in human plasma and study its pharmacokinetics. METHODS: The plasma sample was injected directly for determination after being deproteinized with methanol and the 3P87 pharmacokinetic software was used for the calculation of pharmacokinetic parameters. RESULTS: The linear range was 20.4~12750; ng·ml -1, the limitation of detection was 5.1 ng·ml -1,within-day RSD < 4.48% (n = 5),between-day RSD < 4.53% (n = 5),the recoveries of epalrestat were 101.09%-105.97%. After oral administration of 50 mg of epalrestat tablet, the results showed that the disposition of epalrestat was conformed to a two-compartment model with t( 1/2 α) = (0.56 ± 0.24) h, t( 1/2 β) = (1.11 ± 0.35) h, t(max) = (1.79 ± 0.57) h, c(max) = (3840.6 ± 968.5) ng·ml -1 and AUC(0-∞) = (13016 ± 2865.4) ng·h·ml -1. CONCLUSION: This method is rapid, accurate and sensitive,it is very suitable for the investigation of clinical pharmacokinetics of epalrestat.